AbbVie Reports Strong U.S. Humira Sales
Update: 2025-09-27
Description
AbbVie Reports Strong U.S. Humira Sales AbbVie's third-quarter results were largely in line with Morningstar's expectations, and we don’t expect any major changes to our fair value estimate.We continue to view the firm as undervalued, with the market not likely fully appreciating its next-generati....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Metadata, PNG, VBR MP3
Comments
In Channel